Trials / Completed
CompletedNCT04448418
The Impact of COVID-19 Outbreak on Trans-population's Health in Italy
Observational Evaluation of the Impact of COVID-19 Outbreak on Transgender Subject's Health and on the Organization of Trans-population Health Care Services
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 111 (actual)
- Sponsor
- Unita Complessa di Ostetricia e Ginecologia · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Accepted
Summary
During the COVID-19 outbreak, it was necessary to remodel the healthcare offer for all categories of subjects in order to minimize unnecessary movements of people while maintaining an adequate level of assistance. This is also true for transgender people, who are periodically requested to come into the clinic for hormonal therapy monitoring and continuation. In our center telemedicine programs dedicated to users have been activated for the remote management of hormone therapy. We use a web-based survey to assess the impact of COVID-19 outbreak on trans-population health and to assess the specific needs of this population in this particular moment.
Detailed description
Use of a dedicated web-based anonymous questionnaire to assess health needs of trans-population during COVID-19 outbreak and to assess specific risk factors for COVID-19 infection. Evaluation of physical and psychological wellbeing of the trans-population during COIVD-19 outbreak in Italy using anonymous validated questionnaires (SF12, IES-R and BECK DEPRESSION INVENTORY)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | web based survey | Assess specific health care needs for the transpopulation during the COVID-19 outbreack using a newly created questionnaire and some validated questionnaries (Impact of Event Scale-Revised, BECK Depression Inventory and the Self-rated Health SF-12) |
Timeline
- Start date
- 2020-05-20
- Primary completion
- 2020-06-20
- Completion
- 2020-06-20
- First posted
- 2020-06-25
- Last updated
- 2021-04-29
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT04448418. Inclusion in this directory is not an endorsement.